Blog

Royal Supply Cartrdige

HOW TO FILL YOUR VAPE CARTRIDGE

Have you ever wonder how your could easily refill your vape cartridge without damaging or ruining it? Worry no more because this guide will explain the step by step procedure on how to properly do it.

1. Unscrew the mouth piece.
This is a gasket on the inside that presses against the cartridge. You will see a thread inside that helps keeps this gasket in place and preventing it from any leakage. After about 3 full turns counter clockwise, the thread should be free from the threads in pole in the middle, however, it will still seem in place.

2.Unscrew the mouthpiece from the cartridge.
Once it’s off, make sure to place the mouth piece somewhere safe so you don’t lose it.

3. Fill the cartridge with the oil of your choice.
Leave a little space at the top so as to not overflow the oil when screwing the mouthpiece back on.

4. Screw the mouthpiece back onto the cartridge.
Turn the mouth piece clockwise and after about 3.5 turns you’ll notice that it’s getting firm.

Washington-State-Law-Marijuana-Packaging

WASHINGTON Packaging and Labeling State Law

Washington’s  labeling and packaging guidelines include the following:

Packaging and labeling requirements.

(1) All usable marijuana and marijuana-infused products must be stored behind a counter or other barrier to ensure a customer does not have direct access to the product.

(2) Any container or packaging containing usable marijuana, marijuana concentrates, or marijuana-infused products must protect the product from contamination and must not impart any toxic or deleterious substance to the usable marijuana, marijuana concentrates, or marijuana-infused product.

(3) Upon the request of a retail customer, a retailer must disclose the name of the certified third-party testing lab and results of the required quality assurance test for any usable marijuana, marijuana concentrate, or marijuana-infused product the customer is considering purchasing.

(4) Usable marijuana, marijuana concentrates, and marijuana-infused products must not be labeled as organic unless permitted by the United States Department of Agriculture in accordance with the Organic Foods Production Act.

(5) The certified third-party testing lab and required results of the quality assurance test must be included with each lot and disclosed to the customer buying the lot.

(6) A marijuana producer must make quality assurance test results available to any processor purchasing product. A marijuana producer must label each lot of marijuana with the following information:

(a) Lot number;
(b) UBI number of the producer; and
(c) Weight of the product.

(7) Marijuana-infused products and marijuana concentrates meant to be eaten, swallowed, or inhaled, must be packaged in child resistant packaging in accordance with Title 16 C.F.R. 1700 of the Poison Prevention Packaging Act or use standards specified in this subsection. Marijuana-infused product in solid or liquid form may be packaged in plastic four mil or greater in thickness and be heat sealed with no easy-open tab, dimple, corner, or flap as to make it difficult for a child to open and as a tamperproof measure. Marijuana-infused product in liquid form may also be sealed using a metal crown cork style bottle cap.

Marijuana-infused solid edible products. If there is more than one serving in the package, each serving must be packaged individually in childproof packaging (see WAC 314-55-105(7)) and placed in the outer package.

Marijuana-infused liquid edible products. If there is more than one serving in the package, a measuring device must be included in the package with the product. Hash marks on the bottle do not qualify as a measuring device. A measuring cap or dropper must be included in the package with the marijuana-infused liquid edible product.

(8)

(9) A producer or processor may not treat or otherwise adulterate usable marijuana with any organic or nonorganic chemical or other compound whatsoever to alter the color, appearance, weight, or smell of the usable marijuana.

(10) Labels must comply with the version of NIST Handbook 130, Uniform Packaging and Labeling Regulation adopted in chapter 16-662

(11) All marijuana and marijuana products when sold at retail must include accompanying material that is attached to the package or is given separately to the consumer containing the following warnings:

(a) “Warning: This product has intoxicating effects and may be habit forming. Smoking is hazardous to your health”;
(b) “There may be health risks associated with consumption of this product”;
(c) “Should not be used by women that are pregnant or breast feeding”;
(d) “For use only by adults twenty-one and older. Keep out of reach of children”;
(e) “Marijuana can impair concentration, coordination, and judgment. Do not operate a vehicle or machinery under the influence of this drug”;
(f) Statement that discloses all pesticides applied to the marijuana plants and growing medium during production and processing.

(12) Labels affixed to the container or package containing marijuana or marijuana products sold at retail must include:

(a) The business or trade name and the sixteen digit Washington state unified business identifier number of the licensees that produced, processed and sold the marijuana or marijuana products. The marijuana retail licensee trade name and Washington state unified business identifier number may be in the form of a sticker placed on the label;
(b) Sixteen digit inventory ID number assigned by the WSLCB’s traceability system. This must be the same number that appears on the transport manifest;
(c) Net weight in ounces and grams or volume as appropriate;
(d) Statement that discloses all pesticides applied to the marijuana plants and growing medium during production of the base marijuana used to create the extract added to infused products; and
(e) If solvents were used, statement that discloses the type of extraction method, including any solvents, gases, or other chemicals or compounds used to produce or that are added to the extract.
(f) Warnings that state: “This product has intoxicating effects and may be habit forming”;
(g) Statement that “This product may be unlawful outside of Washington state”;
(h) The WSLCB may create a logo that must be placed on all usable marijuana and marijuana-infused products.

(13) In addition to requirements in subsection (10) of this section, labels affixed to the container or package containing usable marijuana, or packaged marijuana mix sold at retail must include:

(a) Concentration of THC (total THC and activated THC-A) and (total and activated -A);
(b) Date of harvest.

(14) In addition to requirements in subsection (10) of this section, labels affixed to the container or package containing marijuana-infused products meant to be eaten or swallowed sold at retail must include:

(a) Date manufactured;
(b) Best by date;
(c) Serving size and the number of servings contained within the unit;
(d) Total milligrams of active THC, or Delta 9 and total milligrams of active ;
(e) List of all ingredients and major food allergens as defined in the Food Allergen Labeling and Consumer Protection Act of 2004;
(f) “Caution: When eaten or swallowed, the intoxicating effects of this drug may be delayed by two or more hours.”

(15) In addition to requirements in subsection (10) of this section, labels affixed to the container or package containing marijuana-infused extract for inhalation, or infused marijuana mix sold at retail must include:

(a) Date manufactured;
(b) Best by date;
(c) Concentration of THC (total Delta 9 and Delta 9 THC-A) and (total and activated -A).

(16) In addition to requirements in subsection (10) of this section, labels affixed to the container or package containing marijuana topicals sold at retail must include:

(a) Date manufactured;
(b) Best by date;
(c) Total milligrams of active tetrahydrocannabinol (THC), or Delta 9 and total milligrams of active .

(17) Other cannabinoids and terpenes may be included on the label if:

(a) The producer or processor has test results from a certified third-party lab to support the claim; and
(b) The lab results are made available to the consumer upon request.

For more information, please refer to the Washington Administrative Code 314-55-105 for Packaging and Labeling Requirements.

Vermont-State-Law-Marijuana-Packaging

VERMONT Packaging and Labeling State Law

Vermont’s labeling and packaging guidelines include the following:

• A registered dispensary shall package all marijuana dispensed in an envelope or other container used and intended for sale.

• A label shall be affixed on the packaging of all marijuana that is dispensed. The label shall identify the particular strain of marijuana and the weight of marijuana contained within the package in gram or ounce units. Marijuana strains shall reflect the properties of the plant.

• Additionally, the label shall contain a statement to the effect that the State of Vermont does not attest to the medicinal value of cannabis, a statement that this product is not for resale, and clearly identify “marijuana” is contained within the packaging.

• The dispensary shall verify the amount of all marijuana dispensed.

• Documentation shall be maintained containing at a minimum the name and registry identification number of the registered dispensary cardholders verifying the amount of marijuana and any errors identified.

For more information, please refer to the Final Proposed Rules Regulating Cannabis for Symptom Relief.

Rhode-Island-State-Law-Marijuana-Packaging

RHODE ISLAND Packaging and Labeling State Law

Rhode Island’s labeling and packaging guidelines include the following:

• (j) A description of the packaging of the useable marijuana that the compassion center shall be utilizing which shall, as a minimum, include:

(1) A label containing the name of the strain, batch, and quantity; and
(2) A statement that the product is for medical use and not for resale.

For more information, please refer to the Rules and Regulations Related to the Medical Marijuana Program.

Oregon-State-Law-Marijuana-Packaging

OREGON Packaging and Labeling State Law

Oregon’s  labeling and packaging guidelines fall under 333-007-0010 Labeling and include the following:

333-007-0030 Marijuana Plant Labeling Requirements Prior to a marijuana plant being sold or transferred to a consumer, patient or designated primary caregiver a tag or label must be affixed to the plant or plant container that has the following information:

(1) Producer’s business or trade name and licensee or registrant number; (2) Business or trade name of licensee or registrant that packaged or distributed the product, if different from the producer; (3) Name of the strain; and (4) Universal symbol. Marijuana Seed Labeling Requirements Prior to marijuana seeds being sold or transferred to a consumer, patient or designated primary caregiver the container holding the seeds must have a label that has the following information: (1) Producer’s business or trade name and licensee or registrant number; (2) Business or trade name of licensee or registrant that packaged or distributed the product, if different from the producer; (3) Name of the strain of seed;(4) Date of harvest; (5) Number of seeds or net weight in U.S. customary and metric units as appropriate; and (6) Universal symbol. Usable Marijuana Labeling Requirements Prior to usable marijuana being sold or transferred to a consumer, patient or designated primary caregiver the container holding the usable marijuana must have a label that has the following information:(1) Producer’s business or trade name and licensee or registrant number; (2) Business or trade name of licensee or registrant that packaged or distributed the product, if different from the producer; (3) For licensees, package unique identification number and for registrants, harvest lot number; (4) Date of harvest; (5) Name of strain; (6) Net weight in U.S. customary and metric units; (7) Concentration of THC and , as calculated under OAR 333-064-0100; (8) Activation time expressed in words or through a pictogram;

(9) Name of the lab that performed any test, any associated test batch number and any test analysis date;

(10) Universal symbol;

(11) For usable marijuana for sale to a consumer, warnings that state:

(a) “For use by adults 21 and older. Keep out of reach of children.”
(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”

(12) For usable marijuana for use by a patient, warnings that state:

(a) “For use by OMMP patients only. Keep out of reach of children.”
(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”

Cannabinoid Topical Labeling Requirements

Prior to a cannabinoid topical product being sold or transferred to a consumer, patient or designated primary caregiver the container holding the cannabinoid product must have a label that has the following information:

(1) Processor’s business or trade name and licensee or registrant number;

(2) Business or trade name of licensee or registrant that packaged or distributed the product, if different from the processor;

(3) For licensees, package unique identification number and for registrants, process lot number;

(4) Product identity (common or usual name);

(5) Date the product was made;

(6) Net weight or volume in U.S. customary and metric units;

(7) Amount suggested for use by the consumer or patient at any one time;

(8) Concentration or amount by weight or volume of THC and in the container;

(9) List of ingredients in descending order or predominance by weight or volume used to process the cannabinoid topical;

(10) Activation time, expressed in words or through a pictogram;

(11) Name of the lab that performed any test, any associated test batch number and any test analysis date;

(12) Universal symbol;

(13) For licensees, a medical grade symbol if applicable;

(14) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”;

(15) For cannabinoid topicals for sale to a consumer, warnings that state:

(a) “For use only by adults 21 and older. Keep out of reach of children.”
(b) “DO NOT EAT” in bold, capital letters.

(16) For cannabinoid topicals for use by a patient, warnings that state:

(a) “For use by OMMP patients only. Keep out of reach of children.”
(b) “DO NOT EAT” in bold, capital letters.

Cannabinoid Edible Labeling Requirements

Prior to a cannabinoid edible being sold or transferred to a consumer, patient or designated primary caregiver the container holding the edible must have a label that has the following information:

(1) Processor’s business or trade name, place of address, and licensee or registrant number;

(2) Business or trade name and place of address of licensee or registrant that packaged or distributed the product, if different from the processor;

(3) Product identity (common or usual name);

(4) For licensees, package unique identification number and for registrants, process lot number;

(5) Date the edible was made;

(6) Net weight or volume in U.S. customary and metric units;

(7) Serving size and number of servings per container;

(8) Concentration or amount by weight or volume of THC and in each serving and in each container;

(9) List of all ingredients in descending order of predominance by weight or volume used to process the cannabinoid edible;

(10) List of potential major food allergens:

(a) Using a “contains” statement to summarize the major food allergen information at the end of or immediately adjacent to the ingredient list; or

(b) Placing the term for the appropriate major food allergen in parenthesis within the ingredient list after the common or usual name of the ingredient derived from that major food allergen;

(11) The amount, in grams, of sodium, sugar, carbohydrates and total fat per serving;

(12) If the edible is perishable, a statement that the edible must be refrigerated or kept frozen;

(13) Name of the lab that performed any test, any associated test batch number and any test analysis date;

(14) Activation time, expressed in words or through a pictogram;

(15) Universal symbol;

(16) For licensees, a medical grade symbol if applicable;

(17) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”;

(18) For cannabinoid edibles for sale to a consumer, warnings that state:

(a) “For use only by adults 21 and older. Keep out of reach of children.”
(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”
(c) “BE CAUTIOUS” in bold, capital letters, followed by “Cannabinoid edibles can take up to 2 hours or more to take effect.”

(19) For cannabinoid edibles for use by a patient warnings that state:

(a) “For use by OMMP patients only. Keep out of reach of children.”
(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”
(c) “BE CAUTIOUS” in bold, capital letters, followed by “Cannabinoid edibles can take up to 2 hours or more to take effect.”

Labeling Requirements for Cannabinoid Concentrates and Extracts

Prior to a cannabinoid concentrate or extract being sold or transferred to a consumer, patient or designated primary caregiver the container holding the concentrate or extract must have a label that has the following information:

(1) Processor’s business or trade name and licensee or registrant number;

(2) Business or trade name of licensee or registrant that packaged or distributed the product, if different from the processor;

(3) For licensees, package unique identification number and for registrants, process lot number;

(4) Product identity (concentrate or extract);

(5) Date the concentrate or extract was made;

(6) Net weight or volume in U.S. customary and metric units;

(7) If applicable, serving size and number of servings per container or amount suggested for use by the consumer or patient at any one time;

(8) Concentration or amount by weight or volume of THC and in each amount suggested for use and in the container;

(9) Activation time, expressed in words or through a pictogram;

(10) Name of the lab that performed any test, any associated test batch number and any test analysis date;

(11) Universal symbol;

(12) For licensees, a medical grade symbol if applicable;

(13) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”;

(14) For cannabinoid concentrates and extracts for sale to a consumer, warnings that state:

(a) “For use only by adults 21 and older. Keep out of reach of children.”
(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”
(c) “DO NOT EAT” in bold, capital letters.

(15) For cannabinoid concentrates and extracts for use by a patient, warnings that state:

(a) “For use by OMMP patients only. Keep out of reach of children.”
(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”
(c) “DO NOT EAT” in bold, capital letters.

Cannabinoid Tincture Labeling Requirements

Prior to a cannabinoid tincture being sold or transferred to a consumer, patient or designated primary caregiver the container holding the tincture must have a label that has the following information:

(1) Processor’s business or trade name, place of address and licensee or registrant number;

(2) Business or trade name and place of address of licensee or registrant that packaged or distributed the product, if different from the processor;

(3) Product identity (common or usual name);

(4) For licensees, package unique identification number and for registrants, process lot number;

(5) Date the tincture was made;

(6) Net weight or volume in U.S. customary and metric units;

(7) Serving size and number of servings per container;

(8) Concentration or amount by weight or volume of THC and in each serving and in each container;

(9) List of all ingredients in descending order of predominance by weight or volume used to process the cannabinoid tincture;

(10) Name of the lab that performed any test, any associated test batch number and any test analysis date;

(11) Universal symbol;

(12) For licensees, a medical grade symbol if applicable;

(13) Activation time expressed in words or through a pictogram;

(14) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”;

(15) For cannabinoid tinctures for sale to a consumer, warnings that state:

(a) “For use only by adults 21 and older. Keep out of reach of children.”

(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”

(16) For cannabinoid tinctures for use by a patient, warnings that state:

(a) “For use by OMMP patients only. Keep out of reach of children.”

(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”

Cannabinoid Products Other than Cannabinoid Edibles, Topicals or Tinctures

Prior to a cannabinoid product other than a cannabinoid edible, topical or tincture being sold or transferred to a consumer, patient or designated primary caregiver the container holding the product must have a label that has the following information:

(1) Processor’s business or trade name and licensee or registrant number;

(2) Business or trade name of licensee or registrant that packaged or distributed the product, if different from the processor;

(3) Place of address for the processor and packager, if applicable;

(4) Product identity (common or usual name);

(5) For licensees, package unique identification number and for registrants, process lot number;

(6) Date the product was made;

(7) Net weight or volume in U.S. customary and metric units;

(8) Serving size and number of servings per container;

(9) Concentration or amount by weight or volume of THC and in each serving and in each container;

(10) List of all ingredients in descending order of predominance by weight or volume used to process the cannabinoid product;

(11) Name of the lab that performed any test, any associated test batch number and any test analysis date;

(12) Universal symbol;

(13) For licensees, a medical grade symbol if applicable;

(14) Activation time expressed in words or through a pictogram;

(15) A statement that reads: “This product is not approved by the FDA to treat, cure, or prevent any disease”;

(16) For cannabinoid products for sale to a consumer, warnings that state:

(a) “For use only by adults 21 and older. Keep out of reach of children.”

(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”

(17) For cannabinoid products for use by a patient, warnings that state:

(a) “For use by OMMP patients only. Keep out of reach of children.”

(b) “It is illegal to drive a motor vehicle while under the influence of marijuana.”

General Label Requirements; Prohibitions; Exceptions

(1) Principal Display Panel.

(a) Every container that contains a marijuana item for sale or transfer to a consumer, patient or designated primary caregiver must have a principal display panel, as that term is defined in OAR 333-007-0020.

(b) If a container is placed within packaging for purposes of displaying the marijuana item for sale or transfer to a consumer, patient or designated primary caregiver, the packaging must have a principal display panel as that term is defined in OAR 333-007-0020.

(c) The principal display panel must contain the product identity, net weight, and universal symbol, if applicable.

(d) If the product is a medical grade cannabinoid product, concentrate or extract processed by a licensee the principal display panel must include the medical grade symbol.

(2) A label required by these rules must:

(a) Be placed on the container and on any packaging that is used to display the marijuana item for sale or transfer to a consumer, patient or designated primary caregiver.

(b) Comply with the National Institute of Standards and Technology (NIST) Handbook 130 (2016), Uniform Packaging and Labeling Regulation, incorporated by reference.

(c) Be in no smaller than 8 point Times New Roman, Helvetica or Arial font;

(d) Be in English, though it can be in other languages; and

(e) Be unobstructed and conspicuous.

(3) A marijuana item may have one or more labels affixed to the container or packaging.

(4) A marijuana item that is in a container that because of its size does not have sufficient space for a label that contains all the information required for compliance with these rules:

(a) May have a label on the container that contains a marijuana item and on any packaging that is used to display the marijuana item for sale or transfer to a consumer, patient or designated primary caregiver that includes at least the following:

(A) Information required on a principal display panel, if applicable for the type of marijuana item;
(B) Licensee or registrant business or trade name and licensee or registrant number;
(C) For licensees, package unique identification number and for registrants, batch or process lot number;
(D) Concentration of THC and ; and
(E) Required warnings; and

(b) Must include all other required label information not listed in subsection (4)(a) of this rule on an outer container or package, or on a leaflet that accompanies the marijuana item.

(5) A marijuana item in a container that is placed in packaging that is used to display the marijuana item for sale or transfer to a consumer, patient, or designated primary caregiver must comply with the labeling requirements in these rules, even if the container qualifies for the exception under section (4) of this rule.

(6) The universal symbol:

(a) Must be at least 0.48 inches wide by 0.35 inches high.

(b) May only be used by licensees or registrants.

(c) May be downloaded at healthoregon.org/marijuana.

(7) Medical grade symbol. The medical grade symbol must be at least 0.35 inches in diameter.

(8) A label may not:

(a) Contain any untruthful or misleading statements including, but not limited to, a health claim that is not supported by the totality of publicly available scientific evidence (including evidence from well-designed studies conducted in a manner which is consistent with generally recognized scientific procedures and principles), and for which there is significant scientific agreement, among experts qualified by scientific training and experience to evaluate such claims; or

(b) Be attractive to minors, as that is defined in OAR 845-025-7000.

(9) A marijuana item that falls within more than one category, for example a product that is both a cannabinoid concentrate and cannabinoid edible, must comply with the labeling requirements that apply to both categories, with the exception of the “DO NOT EAT” warning if the product is intended for human consumption or the “BE CAUTIOUS” warning if the effects of the product are customarily felt immediately.

(10) The THC and amount required to be on a label must be the value calculated by the laboratory that did the testing in accordance with OAR 333-064-0100.

(11) If a marijuana item has more than one test batch number, laboratory, or test analysis date associated with the marijuana item that is being sold or transferred, each test batch number, laboratory and test analysis date must be included on a label.

(12) If a marijuana item is placed in a package that is being re-used, the old label or labels must be removed and it must have a new label or labels.

(13) A licensee or registrant must have documentation that demonstrates the validity of the calculation of the amount of sodium, sugar, carbohydrates and total fat in a cannabinoid edible and must make that documentation available to the Commission or the Authority upon request.

(14) Exit packaging must contain a label that reads: “Keep out of the reach of children.”

Pre-Approval of Labels

(1) A registrant must submit labels for pre-approval in accordance with OAR 845-025-7060 and must keep all records related to the pre-approval process and provide those records at the request of the Authority.

(2) On and after October 1, 2016, a registrant may not transfer a marijuana item unless the label has been pre-approved in accordance with OAR 845-025-7060.

For more information, please refer to the Marijuana Labeling and Concentration Limits.

 

New York-State-Law-Marijuana-Packaging

NEW YORK Marijuana Packaging and Labeling State Law

New York’s cannabis labeling and packaging guidelines include the following:

• (g) Approved medical marihuana products shall be limited to the following forms and routes of administration:

(1) liquid or oil preparations for metered oromucosal or sublingual administration or administration per tube;
(2) metered liquid or oil preparations for vaporization;
(3) capsules for oral administration; or
(4) any additional form and route of administration approved by the commissioner. Smoking is not an approved route of administration.
(5) approved medical marihuana products may not be incorporated into edible food products by the registered organization, unless approved by the commissioner.

(h) The registered organization shall package the final form of the approved medical marihuana product at the manufacturing site. The original seal shall not be broken except for quality testing at an approved laboratory, for adverse event investigations, by the department, or by the certified patient or designated caregiver.

(i) The registered organization shall package the approved medical marihuana product such that it is child-resistant, tamper-proof/tamper-evident, light-resistant, and in a resealable package that minimizes oxygen exposure.

(j) The registered organization shall identify each lot of approved medical marihuana product with a lot unique identifier.

(k) Each approved medical marihuana product shall be affixed with a product label. Medical marihuana product labels shall be approved by the department prior to use. Each product label shall be applied at the manufacturing facility, be easily readable, firmly affixed and include:

(1) the name, address and registration number of the registered organization;
(2) the medical marihuana product form and brand designation;
(3) the single dose THC and content for the product set forth in milligrams (mg);
(4) the medical marihuana product lot unique identifier (lot number or bar code);
(5) the quantity included in the package;
(6) the date packaged;
(7) the date of expiration of the product;
(8) the proper storage conditions;
(9) language stating:

(i) “Medical marihuana products must be kept in the original container in which they were dispensed and removed from the original container only when ready for use by the certified patient”;
(ii) “Keep secured at all times”;
(iii) “May not be resold or transferred to another person”; (iv) “This product might impair the ability to drive”;
(v) “KEEP THIS PRODUCT AWAY FROM CHILDREN (unless medical marihuana product is being given to the child under a practitioner’s care”); and
(vi) “This product is for medicinal use only. Women should not consume during pregnancy or while breastfeeding except on the advice of the certifying practitioner, and in the case of breastfeeding mothers, including the infant’s pediatrician.”

(l) For each lot of medical marihuana product produced, the registered organization shall submit a predetermined number of final medical marihuana products (e.g., sealed vials or capsules; with the number of samples submitted, based on statistical analysis, determined to be representative of the lot) to an independent laboratory/laboratories approved by the department. The laboratory verifying the cannabinoid content shall be approved for the analysis of medical marihuana product by the department in accordance with section five hundred two of the public health law and subpart 55-2 of this title. Such laboratory, or approved laboratories cumulatively, shall certify the medical marihuana product lot as passing all contaminant testing and verify that the content is consistent with the brand prior to the medical marihuana product being released from the manufacturer to any dispensing facility.

(1) Any lot not meeting the minimum standards or specifications for safety shall be rejected and destroyed by the registered organization in accordance with the registered organization’s approved operating plan.

(2) Any lot not meeting the minimum standards or specifications for brand consistency shall be rejected and destroyed by the registered organization in accordance with the registered organization’s approved operating plan.

(3) The registered organization shall keep and maintain records documenting submission of medical marihuana products to approved laboratories as required herein, and the results of the laboratory testing. The registered organization shall provide the department with such records upon request.

(m) The registered organization shall demonstrate the stability of each approved medical marihuana product produced (each brand in each form) by testing at an approved laboratory in accordance with section 1004.14 of this title:

(1) the stability and expiration date of the final distributed medical marihuana product shall be validated and shall be stable for a minimum of 60 days under the specified storage conditions (light, temperature and humidity) when opened;

(2) shelf-life of unopened medical marihuana products (e.g., packages or vials) shall be validated by ongoing stability testing according to a schedule determined by the department and an expiration date for unopened products shall be determined through the stability testing;

(3) specifications regarding storage conditions must address storage at the manufacturing facility once the package is sealed, during transport, at the dispensing facility, in the patient’s home and for samples retained for future testing.
(n) No synthetic marijuana additives shall be used in the production of any medical marihuana product.

For more information, please refer to the New York Medical Marijuana Program Regulations.

New Mexico -State-Law-Marijuana-Packaging

NEW MEXICO Marijuana Packaging and Labeling State Law

New Mexico’s cannabis labeling and packaging guidelines include the following:

• Packaging and labeling: a manufacturer applicant shall submit a description and sample of the opaque, child-resistant packaging of the concentrate or cannabis-derived product that the manufacturer shall utilize, including a label that shall contain:

(1) the name of the entity that produced the cannabis and the name of the manufacturer;

(2) a batch number or code;

(3) a production date or expiration date, including a “use by” or “freeze by” date for products capable of supporting the growth of infectious, toxigenic, or spoilage microorganisms;

(4) a description of the number of units of usable cannabis contained within the product;

(5) instructions for use;

(6) warnings for use;

(7) instructions for appropriate storage;

(8) approved laboratory analysis, including the results of strength and composition within ten percent (10%) of numbers shown on the package;

(9) the name of the strain, product facts, or a nutrition fact panel, and a statement that the product is for medical use by qualified patients, to be kept away from children, and not for resale; and

(10) the name of the department-approved testing facility or facilities used for ingredient testing, and the type(s) of testing conducted.

For more information, please refer to Title 7, Chapter 34, Part 4 – Licensing Requirements for Producers, Couriers, Manufacturers and Laboratories.

New JerseyState-Law-Marijuana-Packaging

NEW JERSEY Marijuana Packaging and Labeling State Law

New Jersey’s cannabis labeling and packaging guidelines include the following:

(b) The ATC–plant cultivation shall place a legible, firmly affixed label containing the information specified in (c) below on each package of medical marijuana it dispenses to an ATC–dispensary and shall not dispense medical marijuana if the package does not bear the label.

(c) The label required pursuant to (b) above shall contain the following:

• The name and address of the alternative treatment center–plant cultivation that produced the medical marijuana;

• The quantity of the medical marijuana contained within the package;

• The date that the ATC–plant cultivation packaged the content;

• A sequential serial number, lot number, and bar code to identify lot associated with manufacturing and processing;

• The cannabinoid profile of the medical marijuana contained within the package, including THC level not to exceed 10 percent;

• Whether the medical marijuana is of the low, medium, or high strength strain;

• A statement that the product is for medical use by a qualifying patient and not for resale; and

• A list of any other ingredients besides medical marijuana contained within the package.

(d) Labeling shall be clear and truthful in all respects and shall not be false or misleading in any particular.

•A label containing any statements about the product other than those specified in this chapter shall contain the following statement prominently displayed, and in boldface type: “This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

For more information, please refer to New Jersey Register Draft Regulations for the Medicinal Marijuana Program.

Nevada - State-Law-Marijuana-Packaging

NEVADA Marijuana Packaging and Labeling State Law

Nevada’s cannabis labeling and packaging guidelines include the following:

NAC 453A.500  Packaging: Generally. (NRS 453A.370)

1.  Any product containing marijuana must be packaged in child-resistant packaging in accordance with 16 C.F.R. § 1700 or the standards specified in subsection 2 or 3.

2.  Except as otherwise provided in subsection 3, marijuana-infused products in solid or liquid form must be packaged in plastic which is 4 millimeters or more in thickness and must be heat-sealed without an easy-open tab, dimple, corner or flap so that it is difficult for a child to open and as a tamperproof measure.

3.  Marijuana-infused products in liquid form may be sealed using a metal crown cork-style bottle cap.

4.  Any container or packaging containing usable marijuana, edible marijuana products or marijuana-infused products must protect the contents from contamination and must not impart any toxic or deleterious substance to the usable marijuana or marijuana product.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014)

NAC 453A.502  Labeling: Generally. (NRS 453A.370)  Each cultivation facility, facility for the production of edible marijuana products or marijuana-infused products and medical marijuana dispensary shall:

1.  Use for labeling all marijuana, edible marijuana products and marijuana-infused products the standard label described in NAC 453A.506 to 453A.512, inclusive;

2.  Exercise strict control over labeling materials issued for use in labeling operations for marijuana, edible marijuana products and marijuana-infused products;

3.  Carefully examine labeling materials issued for a batch for identity and conformity to the labeling specified in the applicable production or control records; and

4.  Have and follow written procedures describing in sufficient detail the control procedures employed for the issuance of labeling.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014)

NAC 453A.504  Labeling as “organic.” (NRS 453A.370)  A cultivation facility or facility for the production of edible marijuana products or marijuana-infused products shall not label usable marijuana, edible marijuana products or marijuana-infused products as “organic” unless the marijuana plants used are produced, processed and certified in a manner that is consistent with the national organic standards established by the United States Department of Agriculture in accordance with the Organic Foods Production Act of 1990.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014)

NAC 453A.506  Maximum unit size; minimum requirements for font and size of label. (NRS 453A.370)

1.  Any medical marijuana establishment that packages marijuana, edible marijuana products or marijuana-infused products must individually package, label and seal the marijuana or marijuana products in unit sizes such that no single unit contains more than a 2 1/2 ounce supply of marijuana.

2.  For marijuana, edible marijuana products or marijuana-infused products that are intended to be dispensed or sold to a holder of a valid registry identification card or his or her designated primary caregiver:

(a) The text used on all labeling must be printed in at least 10-point font and may not be in italics; and

(b) Each label must be at least 2 3/4 inches high by 4 inches wide.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014)

NAC 453A.508  Labeling requirements for marijuana and related products for sale to medical marijuana dispensary. (NRS 453A.370)

1.  A cultivation facility or facility for the production of edible marijuana products or marijuana-infused products shall label all marijuana, edible marijuana products and marijuana-infused products before it sells the marijuana or marijuana products to a medical marijuana dispensary and shall securely affix to the package a label that includes, without limitation, in legible English:

(a) The name of the medical marijuana establishment and its medical marijuana establishment registration certificate number;

(b) The lot number;

(c) The date of harvest;

(d) The date of final testing;

(e) The date on which the product was packaged;

(f) The cannabinoid profile and potency levels and terpinoid profile as determined by the independent testing laboratory;

(g) If the product is perishable, the expiration date; and

(h) The quantity of marijuana being sold.

2.  The label required by subsection 1 for a container or package containing usable marijuana, edible marijuana products or marijuana-infused products sold by a cultivation facility or facility for the production of edible marijuana products or marijuana-infused products must be in substantially the following form:

JT’S NURSERY

Certificate Number: 123 456 789 001 0001

Lot Number:

1234

Harvested on:

01/01/2013

Final Testing Date: 01/15/2013

Packaged on: 01/17/2013

Best if used by: March 17, 2013

16.7% THC   1.5%    0.3% CBN

Myrcene 5.6 mg/g   Limonene 5.1 mg/g   Valencene 3.5 mg/g

Net Weight: 2 lbs.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014)

NAC 453A.510  Labeling requirements for usable marijuana sold at retail; accompanying materials. (NRS 453A.370)

  1. A medical marijuana dispensary must affix to each container or package containing usable marijuana sold at retail a label which must include, without limitation:

Adopted Regulation R148-15

(a) The business or trade name and the medical marijuana establishment registration certificate number of the cultivation facility that cultivated and sold the usable marijuana.

(b) The lot number.

(c) The date and quantity dispensed, including the net weight measured in ounces and grams or by volume, as appropriate.

(d) The name and registry identification card number of the patient and, if applicable, the name of his or her designated primary caregiver, or, if the patient holds a letter of approval, the name of the patient and the name and number of the registry identification card of his or her designated primary caregiver.

(e) The name and address of the medical marijuana dispensary.

(f) The cannabinoid profile and potency levels and terpenoid profile as determined by the independent testing laboratory, which may include the potential total THC but shall not include any other calculated level of THC.

(g) A warning that states: “This product may have intoxicating effects and may be habit forming.”

(h) The statement: “This product may be unlawful outside of the State of Nevada.”

(i) The date on which the marijuana was harvested.

  1. The label required by subsection 1 for a container or package containing usable marijuana sold at retail must be in substantially the following form:
Joe’s Plant Emporium                             Cert.#: 123 456 789 001 0001

Lot#: 1234                                                          Harvested: 01/01/2013

Dispensed to: John J. Smith  #1234987 on 11/27/2013

by

We Care Dispensary

123 Main Street, Carson City, NV 89701

WARNING:

This product may have intoxicating effects

and may be habit forming.

16.7% THC   1.5%    0.3% CBN

Myrcene 5.6 mg/g   Limonene 5.1 mg/g   Valencene 3.5 mg/g

Net Weight: .25 ounces (7 grams)

This product may be unlawful outside the State of Nevada.

3.  A medical marijuana dispensary must provide with all usable marijuana sold at retail accompanying material that discloses any pesticides applied to the marijuana plants and growing medium during production and processing and contains the following warnings:

(a) “Warning: This product may have intoxicating effects and may be habit forming. Smoking is hazardous to your health.”

(b) “There may be health risks associated with consumption of this product.”

(c) “Should not be used by women who are pregnant or breast feeding.”

(d) “For use only by the person named on the label of the dispensed product. Keep out of the reach of children.”

(e) “Marijuana can impair concentration, coordination and judgment. Do not operate a vehicle or machinery under the influence of this drug.”

4.  The text used on all accompanying material must be printed in at least 12-point font and may not be in italics.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014)

NAC 453A.512  Labeling requirements for edible marijuana products or marijuana-infused products sold at retail; accompanying materials. (NRS 453A.370)

1.  A medical marijuana dispensary must affix to each container or package containing edible marijuana products or marijuana-infused products sold at retail a label which must include, without limitation:

(a) The business or trade name and the medical marijuana establishment registration certificate number of the facility for the production of edible marijuana products or marijuana-infused products that manufactured and sold the product.

(b) The lot numbers of all marijuana used to create the product.

(c) The batch number of the product.

(d) The date and quantity dispensed, including the net weight in ounces and grams or by volume, as appropriate.

(e) The name and registry identification card number of the patient and, if applicable, the name of his or her designated caregiver.

(f) The name and address of the medical marijuana dispensary.

(g) The date on which the product was manufactured.

(h) If the product is perishable, a suggested use-by date.

(i) The total milligrams of active cannabinoids and terpinoids in the product, as provided by the independent testing laboratory that tested the product.

(j) A list of all ingredients and all major food allergens as identified in 21 U.S.C. §§ 343.

(k) A warning that states: “Caution: When eaten or swallowed, the intoxicating effects of this drug may be delayed by 2 or more hours.”

(l) If a marijuana extract was added to the product, a disclosure of the type of extraction process and any solvent, gas or other chemical used in the extraction process, or any other compound added to the extract.

(m) A warning that states: “This product may have intoxicating effects and may be habit forming.”

(n) A statement that: “This product may be unlawful outside of the State of Nevada.”

2.  The front and back of the label required by subsection 1 for a container or package containing edible marijuana products or marijuana-infused products sold at retail must be in substantially the following form:

We Care Dispensary, 123 Main Street, Carson City, NV 89701

Date Dispensed: 3/27/2014  To: John J. Smith #1234987

Cookie

Net Weight:  6oz (168 Grams)

Serving Size:  10mg of THC

Contains 10 servings and a total of 100 MG of THC

Use by:  6/3/2014

Myrcene 5.6 mg/g   Limonene 5.1 mg/g   Valencene 3.5 mg/g

CAUTION: When eaten or swallowed the intoxicating effects of this product can be delayed 2 or more hours.

This product may be unlawful outside the State of Nevada.

Manufactured at: Joe’s Kitchen          Cert.#: 321654987101 0401

123 Main Street, Las Vegas, NV on 2/1/14

Lot#: 1234 Batch #5463

INGREDIENTS: Flour, Butter, Canola Oil,

Sugar, Chocolate, Marijuana, Strawberries

CONTAINS ALLERGENS: Milk, Wheat

Contains marijuana extract processed with butane.

WARNING: This product may have intoxicating effects and may be habit forming.

3.  A medical marijuana dispensary must provide with all edible marijuana products and marijuana-infused products sold at retail accompanying material that discloses any pesticides applied to the marijuana plants and growing medium during production of the marijuana used to create the extract added to the edible marijuana products or marijuana-infused products and the type of extraction method used, including, without limitation, any solvents, gases or other chemicals or compounds used to produce or that are added to the extract, and contains the following warnings:

(a) “There may be health risks associated with consumption of this product.”

(b) “This product contains or is infused with marijuana or active compounds of marijuana.”

(c) “Should not be used by women who are pregnant or breast feeding.”

(d) “For use only by the person named on the label of the dispensed product. Keep out of the reach of children.”

(e) “Products containing marijuana can impair concentration, coordination and judgment. Do not operate a vehicle or machinery under the influence of this drug.”

(f) “Caution: When eaten or swallowed, the intoxicating effects of this drug may be delayed by 2 or more hours.”

4.  The text used on all accompanying material must be printed in at least 12-point font and may not be in italics.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014)

NAC 453A.514  Required examinations of packaged and labeled products. (NRS 453A.370)  Each cultivation facility, facility for the production of edible marijuana products or marijuana-infused products and medical marijuana dispensary shall:

1.  Examine packaged and labeled products during finishing operations to provide assurance that the containers and packages have the correct labels;

2.  Collect a representative sample of units at the completion of finishing operations and ensure that the samples are visually examined for correct labeling; and

3.  Record the results of the examinations performed pursuant to subsections 1 and 2 in the applicable production or control records.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014)

Requirements for the Production of Edible Marijuana Products and Marijuana-Infused Products

NAC 453A.550  “Potentially hazardous marijuana products and ingredients” defined. (NRS 453A.370)  As used in NAC 453A.550 to 453A.592, inclusive, unless the context otherwise requires:

1.  “Potentially hazardous marijuana products and ingredients” means an edible item that is natural or synthetic and that requires temperature control because it is in a form capable of supporting:

(a) The rapid and progressive growth of infectious or toxigenic microorganisms;

(b) The growth and toxin production of Clostridium botulinum; or

(c) In raw shell eggs, the growth of Salmonella Enteritidis.

2.  The term “potentially hazardous marijuana products and ingredients” includes, without limitation:

(a) An animal item that is raw or heat-treated;

(b) An item of plant origin that is heat-treated or consists of raw seed sprouts;

(c) Cut melons and tomatoes; and

(d) Garlic-in-oil mixtures that are not modified in a way that results in mixtures which prohibit growth.

3.  The term “potentially hazardous marijuana products and ingredients” does not include:

(a) An ingredient with a value of water activity of 0.85 or less;

(b) An ingredient with a pH level of 4.6 or below when measured at 75°F (24°C); or

(c) An ingredient, in a hermetically sealed and unopened container, that is commercially processed to achieve and maintain commercial sterility under conditions of nonrefrigerated storage and distribution.

(Added to NAC by Div. of Pub. & Behavioral Health by R004-14, 3-28-2014, eff. 4-1-2014) For more information, please refer to Chapter 453A – Medical Use of Marijuana.